Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2012
12/11/2012CA2284459C Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
12/09/2012CA2779710A1 F11 receptor (f11r) antagonists as therapeutic agents
12/06/2012WO2012166610A1 A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
12/06/2012WO2012165900A2 Peptide bfp 4 for promoting bone formation or vasculogenesis, and application therefor
12/06/2012WO2012164380A2 Dispersion and detachment of cell aggregates
12/06/2012WO2012163533A1 T cell epitope of candida albicans
12/06/2012WO2012061662A9 Glycomimetic-peptidomimetic inhibitors of e-selectins and cxcr4 chemokine receptors
12/06/2012US20120309938 Hemiasterlin derivatives and uses thereof in the treatment of cancer
12/06/2012US20120309696 Acth antagonist peptides
12/06/2012US20120309695 Crystalline form of linaclotide
12/06/2012US20120309692 Activation of Peptide Prodrugs by hK2
12/06/2012US20120309676 Lantibiotic Salts
12/06/2012US20120309675 Peptide bfp4 for promoting osteogenesis or vascularization and use thereof
12/06/2012US20120309091 Methods And Compositions For Gene Inactivation
12/06/2012US20120309045 Composite Probes and Use Thereof in Super Resolution Methods
12/06/2012US20120309015 Methods and compositions for detecting endometrial or ovarian cancer
12/06/2012US20120308638 Antimicrobial peptides
12/06/2012US20120308594 Hcv clade and prototype sequences thereof
12/06/2012US20120308591 Tmem22 peptides and vaccines including the same
12/06/2012US20120308590 Imp-3 oligopeptides and vaccines including the same
12/06/2012US20120308570 Methods for treating diseases
12/06/2012US20120308520 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
12/06/2012US20120308513 Promiscuous her-2/neu cd4 t cell epitopes
12/06/2012CA2837412A1 Dispersion and detachment of cell aggregates
12/06/2012CA2836946A1 A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
12/05/2012EP2529748A2 Vaccine
12/05/2012EP2528938A2 Pro-angiogenic fragments of prominin-1 and uses thereof
12/05/2012EP2528937A1 Modified melk peptides and vaccines containing the same
12/05/2012EP2528936A1 Cyclic peptides binding cxcr4 receptor and relative medical and diagnostic uses
12/05/2012EP2528935A2 Peptide domains that bind small molecules of industrial significance
12/05/2012EP2528934A1 Aromatic-cationic peptides and uses of same
12/05/2012CN102812043A Method For Producing T Cell Receptor-like Monoclonal Antibodies And Uses Thereof
12/05/2012CN102812038A Treatments For Gastrointestinal Disorders
12/05/2012CN102811744A Chemically Modified Cell-penetrating Peptides For Improved Delivery Of Gene Modulating Compounds
12/05/2012CN102807609A Polypeptide for preventing and/or treating pain and application of polypeptide
12/05/2012CN102807608A Peptide sequences and compositions
12/05/2012CN102807607A Fused ring heterocycle compound for restraining hepatitis c virus, midbody and application of fused ring heterocycle compound
12/05/2012CN102807606A Oligopeptide with antitumor and antiadhesion activities and synthesis method and application thereof
12/05/2012CN102807605A Nalpha-(1,3-dioxo-4,4,5,5-tetramethylimidazoline-2-phenyl-4'-oxyacetyl)-Nomega-fatty acyl-Lys-Arg-Gly-Asp-Phe and preparation method and application thereof
12/05/2012CN102807604A N alpha-(1,3-dioxy-4,4,5,5-tetramethyl imidazoline-2-phenyl-4'-oxo acetyl)-N omega-fatty acyl-Lys-Arg-Gly-Asp-Val and preparation method and application thereof
12/05/2012CN102807603A Aliphatic amine chain modified anti-tumor oligopeptide and synthetic method and application thereof
12/05/2012CN102219829B Antioxidant polypeptide prepared by enzymatic hydrolysis of sharkskin collagen with acid protease
12/05/2012CN101974072B Escherichia coli TolC antigen as well as antibody and application thereof
12/05/2012CN101885757B Avian influenza hemagglutinin, epitope peptide, monoclonal antibodies for resisting avian influenza hemagglutinin and epitope peptide, and applications of monoclonal antibodies
12/05/2012CN101370517B Peptide derived from hepatitis C virus
12/04/2012US8324386 Somatostatin-dopamine chimeric analogs
12/04/2012US8324347 Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry
12/04/2012US8324346 Bioactive keratin peptides
12/04/2012US8324345 HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same
12/04/2012US8324344 Membrane transduction peptides and methods of delivering material to a target cell
12/04/2012US8324169 VEGF-activated ligands
12/04/2012US8324154 Treatment of fungal infections with cyclic antimicrobial peptides
12/04/2012US8324152 Composition for the treatment of atherosclerosis
12/04/2012US8323918 Chloroacetamidine based inhibitors and activity based probes for the protein arginine methytransferases
12/04/2012CA2575768C Method for screening toxin neutralizing peptide, stx2 inhibiting peptide and verotoxin neutralizing agent
12/04/2012CA2349442C Compositions and methods for wt1 specific immunotherapy
11/2012
11/29/2012WO2012162679A1 Phoenixin peptides
11/29/2012WO2012162534A2 Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
11/29/2012WO2012162412A2 Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use
11/29/2012WO2012161497A2 Peptide derivatives having a superior moisturizing effect and uses thereof
11/29/2012WO2012160990A1 Igf-1r-binding peptide
11/29/2012WO2012159997A1 Modified tyrosine amino acids, peptides containing them, and their use for detecting hydrolase enzyme activity
11/29/2012WO2012159164A1 Method of determining, identifying or isolating cell-penetrating peptides
11/29/2012WO2012098281A3 Trp-receptor-modulating peptides and uses thereof
11/29/2012US20120302729 Anticancer anti-mortalin peptide antibody
11/29/2012US20120302728 Actagardine Derivatives, and Pharmaceutical Use Thereof
11/29/2012US20120302650 Insulin-Like Growth Factor 1 Receptor (IGF1R) Protein SRM/MRM Assay
11/29/2012US20120302511 Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer
11/29/2012US20120302509 Compositions and methods to prevent cancer with cupredoxins
11/29/2012US20120302506 Maspin-based treatment and prevention of cancer
11/29/2012US20120302493 Cyclic Peptides As G-Protein Coupled Receptor Antagonists
11/29/2012US20120301495 Antigen peptide and use thereof
11/29/2012US20120301490 Immunoconjugates, compositions for making them, and methods of making and use
11/29/2012US20120301474 Compositions and methods for immunization against drug resistant acinetobacter baumannii
11/29/2012US20120301434 Antibacterial polypeptides and use thereof
11/29/2012US20120301400 Meditopes and meditope-binding antibodies and uses thereof
11/29/2012CA2837096A1 Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
11/29/2012CA2836131A1 Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use
11/29/2012CA2834577A1 Method of determining, identifying or isolating cell-penetrating peptides
11/28/2012EP2527360A2 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
11/28/2012EP2527359A2 Diagnostic assay
11/28/2012EP2527358A2 Diagnostic assay
11/28/2012EP2527357A2 Diagnostic assay
11/28/2012EP2527008A2 Anticancerous polymeric agents
11/28/2012EP2526958A1 Methods and compositions for the treatment of gastrointestinal disorders
11/28/2012EP2526201A1 Method for determining the activity of transglutaminase factor xiiia
11/28/2012CN1620174B Cellular telecommunication system
11/28/2012CN102803287A Biologically produced cyclic affinity tags
11/28/2012CN102803286A Process for production of peptide thioester
11/28/2012CN102796179A Template - fixed peptidomimetics with antimicrobial activity
11/28/2012CN102796178A Solid-phase synthesis method of carbetocin
11/28/2012CN102796177A Transformed antibacterial peptide, preparation method and application
11/28/2012CN102796176A Kunyuenin, preparation method and application
11/28/2012CN102796175A Polypeptide bound with high affinity of vasoactive intestinal peptide I type acceptor and application
11/28/2012CN102796174A Epitope for sicca syndrome and application thereof
11/28/2012CN102796173A Epitope of rheumatoid arthritis and application thereof
11/28/2012CN102796172A Hepatitis B virus (HBV) specific human leukocyte antigen-A33 (HLA-A33) restrictive epitope peptides and application thereof
11/28/2012CN102268070B Substrate metal prolease-9 polypeptide inhibitor 2 and application thereof
11/28/2012CN102268069B Substrate metal prolease-9 polypeptide inhibitor 4 and application thereof
11/28/2012CN102040654B Polypeptide TF1 for inhibiting activity of shiga toxin (stx) 2 and coding gene and application of stx2
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 423